Related Experiment Video
Updated: Aug 16, 2026
Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
Published on: September 13, 2022
Differential protein expression profile in gastrointestinal stromal tumors
B Landuyt1, H Prenen, M Debiec-Rychter
1Laboratory of Experimental Oncology (LEO), University Hospital Gasthuisberg, Catholic University of Leuven, Leuven, Belgium. bart.landuyt@med.kuleuven.ac.be
Abstract:
Gastrointestinal stromal tumors (GISTs) arise from the interstitial cells of Cajal through gain of function mutations of the oncogene KIT. Imatinib offers the first effective treatment for patients with GISTs, but the therapeutic outcome strongly depends on the type of KIT mutation. We used ProteinChip technology to investigate whether GISTs with different KIT mutations express different proteins. In total, 154 proteins were significantly differentially expressed in GISTs with exon 9 KIT mutation compared to GISTs with exon 11 KIT mutation.
Insights
Gastrointestinal stromal tumors (GISTs) with different KIT mutations show distinct protein expression profiles. ProteinChip analysis revealed 154 differentially expressed proteins between exon 9 and exon 11 KIT mutations in GISTs.
Area of Science:
- Oncology
- Molecular Biology
- Proteomics
Background:
- Gastrointestinal stromal tumors (GISTs) originate from interstitial cells of Cajal.
- Gain-of-function mutations in the KIT oncogene drive GIST development.
- Imatinib is a primary treatment for GISTs, but efficacy varies with KIT mutation type.
Purpose of the Study:
- To explore differences in protein expression between GISTs harboring distinct KIT mutations.
- To investigate the utility of ProteinChip technology for GIST subtyping.
Main Methods:
- Utilized ProteinChip technology for proteomic analysis.
- Compared protein expression profiles of GISTs with exon 9 KIT mutations versus exon 11 KIT mutations.
Main Results:
- Identified 154 proteins with significant differential expression.
- Observed distinct proteomic signatures correlating with specific KIT mutations (exon 9 vs. exon 11).
Conclusions:
- GISTs with different KIT mutations exhibit unique protein expression patterns.
- Proteomic profiling may aid in understanding GIST heterogeneity and guiding therapeutic strategies.
